Nurul Ain binti Ahmad Zawawi

Ms. Nurul Ain binti Ahmad Zawawi

Tissue Engineering & Regenerative Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NZNurul Ain binti Ahmad Zawawi
Nurul Ain binti Ahmad Zawawi
HAHaslina Ahmad
Haslina Ahmad
RMRajesh Madatheri
Rajesh Madatheri
Nur Izzah Md FadilahNur Izzah Md Fadilah
Nur Izzah Md Fadilah
MMManira Maarof
Manira Maarof
Mh Busra FauziMh Busra Fauzi
Mh Busra Fauzi
Eczema is a complex autoimmune condition characterised mainly by inflammation and skin lesions along with physical and psychological comorbidities. Although there have been significant advances in understanding the mechanisms behind atopic dermatitis, conventionally available treatments yield inconsistent results and have some unintended consequences. In today’s digital age, where knowledge is just a click away, natural-based supplements have been on the rise for a more “natural” treatment towards any type of disease. Natural compounds, particularly derived from medicinal plants, have piqued significant interest in the development of herbal remedies for chronic inflammatory skin conditions. Among many compounds, flavonoids have shown promise in treating eczema due to their strong anti-inflammatory, antioxidant, and anti-allergic properties, making them helpful in preventing allergic reactions, inflammation, and skin irritation. This review highlights the therapeutic potential of flavonoid-based bioactive compounds to manage eczema, emphasising the mechanisms of action. Additionally, providing a comprehensive analysis of the potential of emerging and established compounds, while bridging a gap between traditional and modern medicine. Flavonoids offer a variety of opportunities for further research and innovative formulations that can maximise its full benefits. Further combination of flavonoids with various approaches such as nanoencapsulation for enhanced bioavailability, hydrogel-based delivery systems for a controlled release, and additive manufacturing for personalised topical formulations, could align with future precision medicine needs.

Verified
Journal Article
Open access
PDF file
NZNurul Ain binti Ahmad Zawawi
Nurul Ain binti Ahmad Zawawi
MMManira Maarof
Manira Maarof
Nur Izzah Md FadilahNur Izzah Md Fadilah
Nur Izzah Md Fadilah
DHDaniel Looi Qi Hao
Daniel Looi Qi Hao
YTYasuhiko Tabata
Yasuhiko Tabata
Mh Busra FauziMh Busra Fauzi
Mh Busra Fauzi
Hydrogel patches have gained significant attention in wound healing applications as they are similar to hydrogel dressings due to their moisture-retentive properties, biocompatibility, and ability to promote tissue regeneration. In this study, gelatin-based hydrogels crosslinked with genipin and incorporated with hyaluronic acid (HA) were developed to enhance mechanical stability, swelling behavior, and structural integrity. Fourier transform infrared (FTIR), thermogravimetric (TGA), and energy-dispersive X-ray (EDX) analyses were conducted and confirmed successful crosslinking and good thermal stability, ensuring hydrogel durability under physiological conditions. The optimized hydrogel (GE_HA_GNP) exhibited a sufficient water vapor transmission rate (WVTR), swelling ratio, and contact angle, allowing for effective wound exudate absorption and hydration maintenance, which is essential for accelerated healing. The findings demonstrate that the crosslinked hydrogels were able to maintain a WVTR of 500 to 1500 gm−2 day−1, a contact angle of >40°, and a swelling ratio of 700–1000%. The combination of genipin as a crosslinker and the addition of HA significantly improved the mechanical properties and biocompatibility of the hydrogels, making them promising candidates for an alternative treatment for atopic dermatitis and a potential wound dress-ing. Furthermore, the hydrogel patches show potential for future drug delivery appli-cations, with further studies required to evaluate their antimicrobial properties and long-term clinical performance.

18 February 2026 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
RRRaniya Adiba Mohd Razif
Raniya Adiba Mohd Razif
AZAndik Nisa Zahra Zainuddin
Andik Nisa Zahra Zainuddin
NZNurul Ain binti Ahmad Zawawi
Nurul Ain binti Ahmad Zawawi
MMManira Maarof
Manira Maarof
HAHaslina Ahmad
Haslina Ahmad
Mh Busra FauziMh Busra Fauzi
Mh Busra Fauzi
Chronic wounds remain a major healthcare concern due to delayed healing and high risk of infection. This study investigates the potential of genipin-crosslinked gelatin and asiaticoside (ASI) as innovative biomaterials ink for wound healing. Hydrogels were prepared using different concentrations of gelatin (9% w/v and 10% w/v) and asiaticoside at 0.05% w/v, with genipin employed as a natural crosslinker to improve mechanical strength. Their physicochemical characteristics, which includes swelling ratio, water vapour transmission rate (WVTR), contact angle, porosity, enzymatic degradation, and surface roughness were systematically evaluated, along with mechanical and cytotoxicity properties. Incorporation of asiaticoside enhanced hydrogel hydrophilicity, reduce porosity, and improved swelling behaviour, while preserving biodegradability and overall structural stability. The WVTR values remained within the optimal wound healing range (1500-2500 g/m2h). Furthermore, asiaticoside-loaded hydrogels demonstrated excellent cytocompatibility, supporting fibroblasts viability at lower concentrations including live/dead assay tests that were conducted. This study demonstrates that genipin-crosslinked gelatin-asiaticoside hydrogels are promising biomaterials ink for accelerated wound healing, with an initial characterization of an injectable formulation guiding their successful optimization to achieve the optimal injectability and printability for tissue engineering and three-dimenstional bioprinting (3D-bioprinting).